HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum levels of pigment epithelium-derived factor, a novel marker of insulin resistance, are independently associated with fasting apolipoprotein B48 levels in humans.

AbstractOBJECTIVES:
Fasting apolipoprotein B48 (apoB48) levels are associated with postprandial hyperlipidemia and carotid artery intima-media thickness (IMT), one of the markers of metabolic derangements and atherosclerosis, respectively. However, it remains unknown whether fasting serum levels of apoB48 are independently correlated with insulin resistance and vascular inflammation in humans.
DESIGN AND METHODS:
The study involved 315 consecutive outpatients in our hospital (218 males and 97 females) with a mean age of 62.0 ± 9.2. We examined which anthropometric, metabolic and inflammatory variables, including serum levels of pigment epithelium-derived factor (PEDF), a novel marker of insulin resistance were independently associated with fasting apoB48. Moreover, we investigated whether fasting apoB48 levels were correlated with atherosclerotic plaque inflammation evaluated by [(18)F]-fluorodeoxyglucose positron emission tomography (FDG-PET). Carotid [(18)F]-FDG uptake, an index of vascular inflammation within the atherosclerotic plaques, was measured as blood-normalized standardized uptake value, known as the target-to-background ratio (TBR).
RESULTS:
Mean serum levels of apoB48, PEDF, carotid IMT and TBR values were 2.77 ± 0.21 μg/mL, 13.45 ± 1.03 μg/mL, 0.71 ± 0.15 mm, and 1.43 ± 0.21, respectively. Univariate analysis revealed that apoB48 levels were weakly, but not significantly associated with TBR (p=0.057). In multiple stepwise regression analysis, triglycerides (p<0.001), male (p=0.039), age (inversely, p=0.010), uric acid (p=0.007), medication for diabetes (p=0.029), and PEDF (p=0.049) were independently correlated to fasting apoB48 levels (R(2)=0.371).
CONCLUSIONS:
The present study reveals that serum levels of PEDF are independently associated with fasting apoB48 levels, suggesting that PEDF level is a novel biomarker that could reflect postprandial hyperlipidemia in humans.
AuthorsNobuhiro Tahara, Sho-ichi Yamagishi, Atsuko Tahara, Masayoshi Takeuchi, Tsutomu Imaizumi
JournalClinical biochemistry (Clin Biochem) Vol. 45 Issue 16-17 Pg. 1404-8 (Nov 2012) ISSN: 1873-2933 [Electronic] United States
PMID22827961 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Apolipoprotein B-48
  • Biomarkers
  • Eye Proteins
  • Glycation End Products, Advanced
  • Nerve Growth Factors
  • Radiopharmaceuticals
  • Serpins
  • pigment epithelium-derived factor
  • Fluorodeoxyglucose F18
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Apolipoprotein B-48 (blood)
  • Biomarkers (blood)
  • Carotid Artery Diseases (blood, diagnostic imaging)
  • Carotid Intima-Media Thickness
  • Eye Proteins (blood)
  • Fasting (blood)
  • Female
  • Fluorodeoxyglucose F18
  • Glycation End Products, Advanced (blood)
  • Humans
  • Insulin Resistance
  • Male
  • Middle Aged
  • Nerve Growth Factors (blood)
  • Plaque, Atherosclerotic (blood, diagnostic imaging)
  • Positron-Emission Tomography
  • Radiopharmaceuticals
  • Regression Analysis
  • Serpins (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: